Allopregnanolone as a Regenerative Therapeutic for Early Alzheimer's Disease: Phase 1b/2a Clinical Trial Outcomes

Category Primary study
JournalNeurology
Year 2022
This article has no abstract
Epistemonikos ID: 6a369721564e20fd7c6215d709e2c0f530433b61
First added on: Feb 14, 2025